Next Generation News and Research

RSS

Comprehensive gene activity database could significantly reduce animal use

A comprehensive database of gene activity in mice across ten disease models, which could significantly reduce animal use worldwide, has been developed by scientists at the Francis Crick Institute, which gives a full picture of the immune response to different pathogens.

29 Jun 2019

Quanterix announces Kevin Hrusovsky, Chairman and Chief Executive Officer, and Founder of Powering Precision Health, as EY Entrepreneur Of The Year 2019 Award Winner in New England

Quanterix, announce Chairman and CEO of Quanterix, and Founder of Powering Precision Health, has been recognized with the Entrepreneur Of The Year 2019 Award.

From Quanterix 28 Jun 2019

$UMN research evaluates impact of multimorbidity on hip fracture probability in older women$

UMN research evaluates impact of multimorbidity on hip fracture probability in older women

New University of Minnesota Medical School research evaluates the impact of multimorbidity on the probability of hip fractures.

28 Jun 2019

Disrupting ChIP Assay Technology with New Advancements

The Chromatrap ChIP technology is a bead-free method of performing ChIP. The potential of the technology emerged from our capabilities in manufacturing porous plastic filters for the filtration and separation of biological materials.

From Chromatrap® - Porvair Sciences Ltd 27 Jun 2019

Bruker announces novel phenomics solutions at Metabolomics 2019

At Metabolomics 2019, Bruker highlights innovative MS and NMR systems, and novel high-value solutions for molecular phenomics and clinical metabolomics.

From Bruker Daltonics 26 Jun 2019

Role of biochip advancements in next-generation sequencing

Biochips are essentially tiny laboratories designed to function inside living organisms, and they are driving next-generation DNA sequencing technologies.

26 Jun 2019

Making Bacterial Infections a Thing of the Past for Chronic Respiratory Conditions

In this interview, Prof. Elborn and Dr. Dixon discuss the issues involving chronic lung conditions such as cystic fibrosis and bacterial respiratory infections.

From Neem Biotech 25 Jun 2019

PhoreMost and C4XD sign neurodegeneration drug discovery collaboration agreement

PhoreMost Limited, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, and C4X Discovery Holdings plc, a pioneering drug discovery company, today announced they have signed a neurodegeneration drug discovery collaboration agreement.

From PhoreMost 25 Jun 2019

LDL-cholesterol does not predict future cardiovascular events in high-risk heart patients

New international study shows that LDL-cholesterol is unable to predict future cardiovascular events and fails to identify those coronary heart disease patients who are at the highest risk and who would benefit most from additional attention and preventive action.

24 Jun 2019

MSK receives approval for new molecular assay from New York State Department of Health

Memorial Sloan Kettering Cancer Center announced that the New York State Department of Health has issued an approval for a new molecular assay called Analysis of Circulating cfDNA to Evaluate Somatic Status.

24 Jun 2019

Lean manufacturing methods spur innovations in the testing of drug delivery devices

The number of people who live with diabetes is on the rise. By estimates of the World Health Organization (WHO), one in eleven people are affected by the disease.

21 Jun 2019

MIT engineers design pliable 3D-printed mesh materials for ankle and knee braces

Hearing aids, dental crowns, and limb prosthetics are some of the medical devices that can now be digitally designed and customized for individual patients, thanks to 3-D printing.

21 Jun 2019

Suppressing amygdala molecule enables faster recovery from PTSD symptoms

Fight or flight, panic, trembling: Our brains are wired to ensure we respond instantly to fear. While that fear response may save our lives in the dangerous moment, at times people stay on high alert long after the threat has passed, and develop post-traumatic stress disorder.

20 Jun 2019

Revolutionary cancer drugs that target any tumor to be fast-tracked into hospitals by NHS

Patients in England could be some of the first in the world to be treated with revolutionary cancer drugs that can target any type of tumor.

19 Jun 2019

Highlights and key takeaways from the 2019 Boston Bacterial Meeting (BBM)

Missed out on the 2019 Boston Bacterial Meeting (BBM)? Read our round-up of the key takeaways, areas of discussion, speakers and more.

19 Jun 2019

New chief medical officer appointed for Cancer Research UK’s Centre for Drug Development

Professor Peter Johnson will be the new chief medical officer for Cancer Research UK’s Centre for Drug Development, it was announced today (Tuesday).

19 Jun 2019

New ZetaView QUATT enhances nanoparticle analysis specificity

Analytik has launched the next generation ZetaView QUATT, with a multi-wavelength video tracking microscope for rapid analysis of size, concentration, fluorescence, electrophoretic mobility and sub-populations of individual nanoparticles.

From Analytik Ltd 19 Jun 2019

Machine learning algorithms applied to biopsy images can improve gut disease diagnosis

A study published in the open access journal JAMA Open Network June 14 by scientists at the University of Virginia schools of Engineering and Medicine and the Data Science Institute says machine learning algorithms applied to biopsy images can shorten the time for diagnosing and treating a gut disease that often causes permanent physical and cognitive damage in children from impoverished areas.

18 Jun 2019

Canadian Institutes of Health Research and partners fund CCNA's second phase

Thanks to a $46-million investment from the Canadian Institutes of Health Research (CIHR) and other funding partners, the Canadian Consortium on Neurodegeneration in Aging (CCNA) will be renewed for a second phase, announced today.

17 Jun 2019

Researchers exploit nanoparticles to develop test for early detection of different diseases

Investigators from Brigham and Women's Hospital are taking advantage of a unique phenomenon of nanoparticles to develop a test for early detection of different types of diseases, including cancer.

17 Jun 2019

Next Generation News and Research

Comprehensive gene activity database could significantly reduce animal use

Quanterix announces Kevin Hrusovsky, Chairman and Chief Executive Officer, and Founder of Powering Precision Health, as EY Entrepreneur Of The Year 2019 Award Winner in New England

UMN research evaluates impact of multimorbidity on hip fracture probability in older women

Disrupting ChIP Assay Technology with New Advancements

Bruker announces novel phenomics solutions at Metabolomics 2019

Role of biochip advancements in next-generation sequencing

Making Bacterial Infections a Thing of the Past for Chronic Respiratory Conditions

PhoreMost and C4XD sign neurodegeneration drug discovery collaboration agreement

LDL-cholesterol does not predict future cardiovascular events in high-risk heart patients

MSK receives approval for new molecular assay from New York State Department of Health

Lean manufacturing methods spur innovations in the testing of drug delivery devices

MIT engineers design pliable 3D-printed mesh materials for ankle and knee braces

Suppressing amygdala molecule enables faster recovery from PTSD symptoms

Revolutionary cancer drugs that target any tumor to be fast-tracked into hospitals by NHS

Highlights and key takeaways from the 2019 Boston Bacterial Meeting (BBM)

New chief medical officer appointed for Cancer Research UK’s Centre for Drug Development

New ZetaView QUATT enhances nanoparticle analysis specificity

Machine learning algorithms applied to biopsy images can improve gut disease diagnosis

Canadian Institutes of Health Research and partners fund CCNA's second phase

Researchers exploit nanoparticles to develop test for early detection of different diseases

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News